Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21

<p><strong>Introduction: </strong>The high proportion of SARS-CoV-2 infections that have remained undetected presents a challenge to tracking the progress of the pandemic and estimating the extent of population immunity.</p> <p><strong>Methods: &...

Bibliografske podrobnosti
Main Authors:	Lucinde, RK, Mugo, D, Bottomley, C, Karani, A, Gardiner, E, Aziza, R, Gitonga, JN, Karanja, H, Nyagwange, J, Tuju, J, Wanjiku, P, Nzomo, E, Kamuri, E, Thuranira, K, Agunda, S, Nyutu, G, Etyang, AO, Adetifa, IMO, Kagucia, E, Uyoga, S, Otiende, M, Otieno, E, Ndwiga, L, Agoti, CN, Aman, RA, Mwangangi, M, Amoth, P, Kasera, K, Nyaguara, A, Ng'ang'a, W, Ochola, LB, Namdala, E, Gaunya, O, Okuku, R, Barasa, E, Bejon, P, Tsofa, B, Ochola-Oyier, LI, Warimwe, GM, Agweyu, A, Scott, JAG, Gallagher, KE
Format:	Journal article
Jezik:	English
Izdano:	Public Library of Science 2022

Podobne knjige/članki

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.
od: Ruth K Lucinde, et al.
Izdano: (2022-01-01)

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21
od: Ruth K. Lucinde, et al.
Izdano: (2022-01-01)

Seroprevalence of antibodies to SARS-CoV-2 among health care workers in Kenya
od: Etyang, AO, et al.
Izdano: (2021)

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
od: Uyoga, S, et al.
Izdano: (2021)

Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study
od: Otiende, M, et al.
Izdano: (2023)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
od: Etyang, AO, et al.
Izdano: (2022)

Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study
od: M. Otiende, et al.
Izdano: (2023-10-01)

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya
od: Nyagwange, J, et al.
Izdano: (2022)

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
od: Adetifa, IMO, et al.
Izdano: (2021)

Anti-severe acute respiratory syndrome coronavirus 2 immunoglobulin g antibody seroprevalence among truck drivers and assistants in Kenya
od: Kagucia, EW, et al.
Izdano: (2021)

Rethinking the evidence on COVID in Africa
od: Bejon, P, et al.
Izdano: (2025)

Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya.
od: Orangi, S, et al.
Izdano: (2022)

COVID-19 transmission dynamics underlying epidemic waves in Kenya
od: Brand, SPC, et al.
Izdano: (2021)

Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
od: Nyagwange, J, et al.
Izdano: (2022)

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
od: Nyagwange, J, et al.
Izdano: (2021)

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
od: Ojal, J, et al.
Izdano: (2021)

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
od: Ojal, J, et al.
Izdano: (2021)

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya [version 1; peer review: 2 approved]
od: Henry Karanja, et al.
Izdano: (2022-02-01)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.
od: Anthony O Etyang, et al.
Izdano: (2022-01-01)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
od: Anthony O. Etyang, et al.
Izdano: (2022-01-01)

Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: a retrospective genomic study
od: Agoti, CN, et al.
Izdano: (2022)

The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study
od: Lucinde, RK, et al.
Izdano: (2023)

The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations
od: Ndwiga, L, et al.
Izdano: (2021)

Understanding P. falciparum Asymptomatic Infections: A Proposition for a Transcriptomic Approach
od: Kelvin M. Kimenyi, et al.
Izdano: (2019-10-01)

No evidence of P. falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites
od: Wamae, K, et al.
Izdano: (2019)

Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya
od: Githinji, G, et al.
Izdano: (2021)

A cross-sectional analysis identifies a low prevalence of Plasmodium ovale species infections in symptomatic and asymptomatic individuals in Kilifi county, Kenya. [version 4; peer review: 2 approved]
od: Leonard Ndwiga, et al.
Izdano: (2024-09-01)

Understanding P. falciparum asymptomatic infections: a proposition for a transcriptomic approach
od: Kimenyi, KM, et al.
Izdano: (2019)

Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
od: Morris Ogero, et al.
Izdano: (2022-08-01)

Optimization of the SARS-CoV-2 ARTIC network V4 primers and whole genome sequencing protocol
od: Lambisia, AW, et al.
Izdano: (2022)

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
od: James Nyagwange, et al.
Izdano: (2023-02-01)

Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya.
od: Okombo, J, et al.
Izdano: (2014)

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
od: Doreen Lugano, et al.
Izdano: (2024-12-01)

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
od: Hamaluba, M, et al.
Izdano: (2023)

Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018
od: Kimenyi, KM, et al.
Izdano: (2022)

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data [version 2; peer review: 2 approved, 1 approved with reservations]
od: Sophie Uyoga, et al.
Izdano: (2022-02-01)

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data [version 3; peer review: 2 approved, 1 approved with reservations]
od: Sophie Uyoga, et al.
Izdano: (2022-09-01)

The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations
od: Leonard Ndwiga, et al.
Izdano: (2021-06-01)

ONT sequencing identifies a high prevalence of crt sensitive, triple mutant dhfr and single mutant dhps parasites within an ANC population in Nigeria
od: Adebanjo Jonathan Adegbola, et al.
Izdano: (2024-10-01)

Amplicon sequencing as a potential surveillance tool for complexity of infection and drug resistance markers in Plasmodium falciparum asymptomatic infections
od: Wamae, K, et al.
Izdano: (2022)